12885_2021_8725_MOESM3_ESM.docx (36.58 kB)
Additional file 3 of How are we evaluating the cost-effectiveness of companion biomarkers for targeted cancer therapies? A systematic review
journal contribution
posted on 2021-09-02, 03:31 authored by Mikyung Kelly Seo, John CairnsAdditional file 3. PRISMA flow diagram of study selection.
History
Usage metrics
Keywords
Licence
Exports
RefWorksRefWorks
BibTeXBibTeX
Ref. managerRef. manager
EndnoteEndnote
DataCiteDataCite
NLMNLM
DCDC